We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTI icon
1001
TechnipFMC
FTI
$28.6B
$11K ﹤0.01%
1,629
HALO icon
1002
Halozyme
HALO
$9.88B
$11K ﹤0.01%
254
-515
-67% -$18.5K
WNS
1003
DELISTED
WNS Holdings
WNS
$11K ﹤0.01%
150
TPTX
1004
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$11K ﹤0.01%
91
-144
-61% -$15.8K
BNTX icon
1005
BioNTech
BNTX
$23.5B
$10K ﹤0.01%
+125
New +$12.3K
PRDO icon
1006
Perdoceo Education
PRDO
$2.17B
$10K ﹤0.01%
810
-100
-11% -$1.2K
EIDX
1007
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10K ﹤0.01%
73
-139
-66% -$12.3K
BEAM icon
1008
Beam Therapeutics
BEAM
$2.68B
$9K ﹤0.01%
+109
New +$5.36K
MEDP icon
1009
Medpace
MEDP
$16.3B
$9K ﹤0.01%
67
-136
-67% -$17.1K
NWS icon
1010
News Corp Class B
NWS
$17.7B
$9K ﹤0.01%
511
PACB icon
1011
Pacific Biosciences
PACB
$435M
$9K ﹤0.01%
352
-512
-59% -$8.7K
CBPO
1012
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$9K ﹤0.01%
73
-144
-66% -$16.7K
APLS
1013
DELISTED
Apellis Pharmaceuticals
APLS
$8K ﹤0.01%
142
-277
-66% -$11.7K
CNQ icon
1014
Canadian Natural Resources
CNQ
$96.9B
$8K ﹤0.01%
+674
New +$6.77K
EDIT icon
1015
Editas Medicine
EDIT
$399M
$8K ﹤0.01%
117
-187
-62% -$7.68K
IMVT icon
1016
Immunovant
IMVT
$7.93B
$8K ﹤0.01%
+184
New +$8.51K
PTCT icon
1017
PTC Therapeutics
PTCT
$6.18B
$8K ﹤0.01%
128
-230
-64% -$13.6K
SAGE
1018
DELISTED
Sage Therapeutics
SAGE
$8K ﹤0.01%
98
-194
-66% -$14.3K
CCXI
1019
DELISTED
ChemoCentryx, Inc.
CCXI
$8K ﹤0.01%
130
-259
-67% -$14.8K
ARNA
1020
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8K ﹤0.01%
109
-209
-66% -$15.7K
ALLO icon
1021
Allogene Therapeutics
ALLO
$625M
$7K ﹤0.01%
264
-523
-66% -$17K
BNS icon
1022
Scotiabank
BNS
$105B
$7K ﹤0.01%
+130
New +$6.16K
OCFT
1023
DELISTED
OneConnect Financial Technology
OCFT
$7K ﹤0.01%
35
RLAY icon
1024
Relay Therapeutics
RLAY
$4B
$7K ﹤0.01%
+169
New +$7.64K
SWTX
1025
DELISTED
SpringWorks Therapeutics
SWTX
$7K ﹤0.01%
+92
New +$5.92K

Similar funds

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.